Treatment of Climacteric Symptoms With Ovaria Comp - A Prospective Randomized Placebo Controlled Doubleblind Study

NCT00152776 Phase 4 COMPLETED

The purpose of this study is to determine whether ovaria comp. is effective in relieving climacteric symptoms.

Details

Lead sponsor	Heidelberg University
Phase	Phase 4
Status	COMPLETED
Enrolment	102
Start date	2005-02
Completion	2006-12

Conditions

• Menopause
• Anxiety Disorders
• Depression

Interventions

• ovaria comp 10 globuli 3 times per day 24 weeks

Primary outcomes

• Climacteric symptoms — 12 weeks
  sum score of the menopause rating scale (MRS II) before and after 12 weeks of treatment

Countries

Germany